RedHill Biopharma Advancing Opaganib Options For Ebola Virus Disease Outbreak

Amid the rapidly evolving Ebola virus disease (EVD) outbreak involving the rare Bundibugyo ebolavirus sub-type, for which there are no approved medications or vaccines, RedHill Biopharma is actively discussing potential collaborations for clinical advancement of opaganib1,

Raccontata daadnkronos.com